U.S. markets closed

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
23.56+1.26 (+5.65%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close22.30
Open22.61
Bid23.56 x 2900
Ask23.60 x 1300
Day's Range22.62 - 23.91
52 Week Range3.32 - 53.69
Volume3,143,708
Avg. Volume3,996,469
Market Cap4.674B
Beta (5Y Monthly)1.12
PE Ratio (TTM)N/A
EPS (TTM)-0.34
Earnings DateAug 02, 2021 - Aug 06, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est51.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences
    GlobeNewswire

    Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences

    MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: BofA Securities 2021 Virtual Health Care Conference on Thursday, May 13, 2021 at 2:00 p.m. EDT UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 at 11 a.m. EDT The live webcasts can be accessed at the company’s investors page at investor.pacificbiosciences.com. The replays will be available for at least 30 days following the presentation. About Pacific Biosciences Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. The company’s innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology. For more information please visit www.pacb.com and follow @PacBio. Contacts Investors: Todd Friedman650.521.8450ir@pacificbiosciences.com

  • Pacific Biosciences (PACB) Down 10.8% Despite Narrower Q1 Loss
    Zacks

    Pacific Biosciences (PACB) Down 10.8% Despite Narrower Q1 Loss

    Pacific Biosciences' (PACB) revenues grow in both its segments during the first quarter.

  • Is Pacific Biosciences of California (PACB) A Good Investment Choice?
    Insider Monkey

    Is Pacific Biosciences of California (PACB) A Good Investment Choice?

    Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 0.58% was delivered by the fund’s institutional shares for the Q1 of 2021, below both its S&P 500 and Russell 3000 Health Care benchmarks that delivered […]